Related Experiment Video
Updated: Jan 22, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Antimicrobial Resistance Patterns in Methicillin-Resistant Staphylococcus aureus from Patients Hospitalized during
Barbara Kot1, Kamila Wierzchowska2, Małgorzata Piechota2
1Department of Microbiology, Faculty of Natural Sciences, Siedlce University of Natural Sciences and Humanities, Siedlce, Poland, barbara.kot@uph.edu.pl.
Objective:
The aim of this study was to determine antimicrobial resistance profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolates from clinical samples from patients hospitalized during 2015-2017 in hospitals of -Masovian district in Poland.
Materials And Methods:
Antimicrobial resistance of 112 MRSA isolates was tested with a disc diffusion method. Isolates were examined for methicillin resistance using a 30 µg cefoxitin disk. Resistance was confirmed by PCR detection of the mecA gene. PCR was also used to determine spa gene polymorphism in X-region.
Results:
A large number of MRSA isolates showed resistance to levofloxacin (83.9%), ciprofloxacin (83%), erythromycin (77.7%) and clindamycin (72.3%). A lower number of MRSA isolates showed resistance to tetracycline (10.7%), amikacin (14.2%), gentamicin and trimethoprim with sulfamethoxazole (8.0%). None of the MRSA isolates were resistant to linezolid and teicoplanin. Among MRSA isolates, 92.9% were multidrug-resistant (MDR). Resistance to erythromycin, clindamycin, ciprofloxacin and levofloxacin was the most common resistance pattern among MDR MRSA isolates. The highest number of isolates was resistant to 4 groups of antimicrobials (53.8%). The number of drugs to which MRSA isolates were resistant in 2017 was significantly higher than that in 2016 (p = 0.002). The size polymorphism analysis of X fragment of the spa gene revealed high genetic diversity of the investigated group MRSA isolates.
Conclusion:
This study demonstrates that in the hospital environment, MRSA isolates can quickly acquire new antimicrobial resistance determinants and that knowledge of current resistance patterns is important for the effective treatment of infections caused by MDR MRSA.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) in Poland shows high resistance to common antibiotics, with most isolates being multidrug-resistant (MDR). This highlights the urgent need for updated treatment strategies against these evolving hospital-acquired infections.
Area of Science:
- Clinical microbiology
- Infectious diseases
- Antimicrobial resistance
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat in hospital settings.
- Understanding the evolving antimicrobial resistance patterns of MRSA is crucial for effective patient management.
Purpose of the Study:
- To determine the antimicrobial resistance profiles of MRSA isolates from clinical samples in Poland.
- To analyze the genetic diversity and resistance patterns of MRSA strains collected between 2015-2017.
Main Methods:
- Antimicrobial susceptibility testing using disc diffusion.
- Confirmation of methicillin resistance via cefoxitin disk and PCR detection of the mecA gene.
- spa gene polymorphism analysis using PCR.
Main Results:
- High resistance rates observed for levofloxacin (83.9%), ciprofloxacin (83%), erythromycin (77.7%), and clindamycin (72.3%).
- No resistance detected for linezolid and teicoplanin.
- 92.9% of MRSA isolates were multidrug-resistant (MDR), with increasing resistance noted from 2016 to 2017.
Conclusions:
- MRSA isolates in hospital environments rapidly acquire new resistance mechanisms.
- Knowledge of current MRSA resistance patterns is essential for guiding effective treatment of MDR MRSA infections.
Related Concept Videos
Hospitals-II
Nurses that work in...
Hospitals-I
Resistivity
Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Equivalent Resistance

